Mode
Text Size
Log in / Sign up

Third-trimester serum ferritin levels associated with intrahepatic cholestasis of pregnancy riskA Simple Blood Test May Predict a Risky Pregnancy Liver Condition

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that increased third-trimester ferritin is associated with ICP risk in an observational study, but causation is not established.

This was a retrospective case-control study at Guizhou Provincial People’s Hospital, examining pregnant patients from January 2023 to March 2025. The study compared serum ferritin levels in pregnancies with intrahepatic cholestasis of pregnancy (ICP) to those in normal pregnancies (healthy controls).

The primary outcome was ICP risk. The main result showed a significant association between increased ferritin levels in the third trimester and ICP risk. The adjusted odds ratio (AOR) was 1.005, with a 95% confidence interval of 1.001–1.008 and a p-value of 0.016. Serum ferritin was ranked as the foremost predictor among covariates.

Safety and tolerability data were not reported. No adverse events, serious adverse events, or discontinuations were noted.

Key limitations include the retrospective design, single-center setting, and that underlying mechanisms remain unclear. The study was observational, and the association reported does not establish causation.

The practice relevance suggests that increased ferritin levels during pregnancy may increase ICP risk, but future large-sample prospective multicenter cohort studies are warranted. Findings require further validation.

Why a Liver Condition During Pregnancy Matters Now

Imagine a pregnant woman in her third trimester. She feels fine, but she has a routine blood test. The results show her iron levels are high. Could this be a warning sign?

This is the question a new study is asking. It focuses on a condition called intrahepatic cholestasis of pregnancy (ICP). This is a liver problem that happens during pregnancy. It causes a buildup of bile acids in the blood.

This buildup can cause severe itching for the mother. More importantly, it can be dangerous for the baby. It increases the risk of preterm birth and other complications. ICP affects about 1 in 1,000 pregnancies, but it can be higher in some regions.

Doctors usually diagnose ICP with a blood test that measures bile acids. But what if we could spot the risk earlier? What if a simple iron test could help?

The Old Way vs. The New Way

For a long time, doctors have focused on bile acids to diagnose ICP. Iron levels were not a major concern. We knew iron was important for the baby’s growth, but we didn’t link high iron to this specific liver problem.

But here’s the twist: New research suggests iron and liver health are connected. When iron levels are too high, it can cause stress in the body. This stress might affect the liver.

This study changes how we think. It suggests that high iron, measured by a protein called ferritin, might be a red flag for ICP. It’s not about the iron in your diet. It’s about how your body stores and uses it.

How Iron and the Liver Connect

Think of your body’s iron storage like a bank account. Ferritin is the bank manager. It keeps track of how much iron is stored.

Normally, this system works well. But during pregnancy, the body’s demands change. If the bank manager (ferritin) shows too much iron is stored, it could mean the system is out of balance.

This imbalance might stress the liver. The liver has to process everything in your body, including iron. If it’s overloaded, it might not work as well. This could lead to the bile acid buildup we see in ICP.

It’s like a traffic jam. If too many cars (iron) are on the road, everything slows down. The liver gets stuck, and problems start.

A Look at the Study

Researchers at Guizhou Provincial People’s Hospital in China looked at this link. They studied pregnant women from January 2023 to March 2025.

They compared two groups:

  • Women with healthy pregnancies.
  • Women diagnosed with ICP.

They measured ferritin levels in both groups. They used advanced computer models to find patterns. This included a method called machine learning to see which factor was most predictive.

The results were clear. Women with ICP had higher ferritin levels than healthy women. This was true throughout pregnancy.

The link was strongest in the third trimester. For every small increase in ferritin, the risk of ICP went up slightly. The numbers showed a clear pattern: higher iron storage meant higher risk.

The computer model ranked ferritin as the top predictor of ICP. It was more important than other factors they looked at.

But here’s the catch: The relationship wasn’t a straight line. In the second trimester, the risk was lowest when ferritin was in a middle range. In the third trimester, the risk went up sharply as ferritin increased.

This doesn’t mean high iron causes ICP. It only shows a strong link.

What Experts Think

This study is one of the first to use machine learning to explore this connection. Experts say it’s a promising step. It suggests that checking iron levels could be a simple way to assess ICP risk.

However, they caution that we don’t yet know why this link exists. Is high iron causing the liver problem, or is the liver problem affecting iron storage? More research is needed to answer this.

If you are pregnant, you might wonder if you should get your ferritin tested. The answer is: not yet.

This study is early. It’s a look back at past data, not a test of a new treatment. Right now, doctors still rely on bile acid tests to diagnose ICP.

If you are pregnant and have itching, especially in the third trimester, talk to your doctor. They can check your bile acids. But don’t worry about ferritin levels just yet. This research is for future use, not for today’s decisions.

This study has some weaknesses. It was done at one hospital in China. The results might not apply to all women everywhere.

It was also a retrospective study, meaning they looked at old data. They didn’t test a new treatment or intervention. We need larger, more diverse studies to confirm these findings.

What happens next? Researchers want to do larger studies. They need to include women from different countries and backgrounds. They also want to understand the biology behind this link.

If the link is confirmed, ferritin tests could become part of routine prenatal care. This could help doctors spot ICP risk earlier and act sooner.

For now, this research gives us a new clue. It shows that a simple iron test might one day help protect both mother and baby.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
IntroductionIntrahepatic cholestasis of pregnancy (ICP) is a gestational metabolic disorder characterized by impaired maternal bile acid homeostasis. Emerging evidence suggests that dysregulated iron metabolism may contribute to the pathophysiology of ICP. Nevertheless, the specific alterations in iron metabolism among ICP patients remain unexplored.MethodsIn our retrospective study, we compared serum ferritin levels between normal pregnancies and ICP cases at Guizhou Provincial People’s Hospital from January 2023 to March 2025. Propensity Score Matching, P for trend, restricted cubic spline analysis, and a random forest algorithm were employed to assess the association between serum ferritin and ICP risk.ResultsElevated serum ferritin concentrations were observed in patients with ICP compared to healthy controls throughout gestation. And it shows a positive correlation with serum hepatic enzyme concentration. PSM analysis identified a significant association between increased ferritin levels in the third trimester and higher ICP risk (AOR = 1.005, 95% CI: 1.001–1.008, p = 0.016). RCS modeling revealed a nonlinear relationship: a U-shaped association in the second trimester, with ferritin concentrations between 21.7 and 53.9 ng/mL conferring no significant alteration in risk, and a J-shaped association in the third trimester. The random forest variable importance analysis ranked serum ferritin as the foremost predictor of ICP among all evaluated covariates.DiscussionIn conclusion, our study suggests that increased ferritin levels during pregnancy may increase the risk of ICP, though the underlying mechanisms remain unclear. Future research involving large-sample prospective multicenter cohort studies is warranted to further elucidate these mechanisms.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.